PubRank

Lucas Liaudet

Author PubWeight™ 120.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007 15.49
2 Early predictors of outcome in comatose survivors of ventricular fibrillation and non-ventricular fibrillation cardiac arrest treated with hypothermia: a prospective study. Crit Care Med 2008 3.14
3 Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 2009 2.83
4 Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol 2007 2.81
5 Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 2003 2.56
6 From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med 2006 2.48
7 The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 2002 2.20
8 The vasodilatory response of skin microcirculation to local heating is subject to desensitization. Microcirculation 2009 2.02
9 Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 2006 1.99
10 Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 2002 1.97
11 Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009 1.89
12 Body temperature regulation and outcome after cardiac arrest and therapeutic hypothermia. Resuscitation 2011 1.78
13 CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol 2007 1.77
14 Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol 2004 1.67
15 Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 2010 1.56
16 Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 2007 1.54
17 Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 2005 1.53
18 Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002 1.44
19 Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium. Crit Care Med 2005 1.40
20 Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 2007 1.39
21 Pulse wave analysis of aortic pressure: diastole should also be considered. J Hypertens 2013 1.39
22 Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 2002 1.36
23 Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol 2007 1.34
24 A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther 2004 1.32
25 Hypertension and microvascular remodelling. Cardiovasc Res 2008 1.26
26 Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med 2011 1.24
27 Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002 1.23
28 CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res 2009 1.22
29 Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med 2006 1.21
30 Hypertension: a disease of the microcirculation? Hypertension 2006 1.21
31 Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem 2010 1.19
32 Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol Rep 2004 1.18
33 Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem 2005 1.13
34 Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol 2002 1.12
35 Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 2012 1.10
36 Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology 2014 1.09
37 Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 2004 1.08
38 The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep 2009 1.07
39 Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 2008 1.05
40 Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis. Biochem Biophys Res Commun 2006 1.04
41 Caspase-3 protects stressed organs against cell death. Mol Cell Biol 2012 1.03
42 Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 2002 1.03
43 Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 2004 1.03
44 Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med 2012 1.02
45 Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management. Crit Care 2012 1.00
46 The role of oxidative stress during inflammatory processes. Biol Chem 2014 0.99
47 Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation. J Cardiovasc Pharmacol 2004 0.99
48 Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res 2010 0.98
49 Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite. Biochem Biophys Res Commun 2007 0.98
50 Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol 2010 0.97
51 Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Physiol Heart Circ Physiol 2010 0.95
52 Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 2002 0.94
53 Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock 2007 0.94
54 Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med 2002 0.93
55 Poly(ADP-ribose)polymerase inhibition decreases angiogenesis. Biochem Biophys Res Commun 2006 0.93
56 Acetylcholine-induced vasodilation and reactive hyperemia are not affected by acute cyclo-oxygenase inhibition in human skin. Microcirculation 2004 0.92
57 Endurance training enhances vasodilation induced by nitric oxide in human skin. J Invest Dermatol 2003 0.90
58 Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice. Crit Care 2010 0.89
59 Carboxyhemoglobin formation as an unexpected side effect of inhaled nitric oxide therapy in severe acute respiratory distress syndrome. Crit Care Med 2004 0.88
60 Bacterial flagellin triggers cardiac innate immune responses and acute contractile dysfunction. PLoS One 2010 0.88
61 Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Curr Vasc Pharmacol 2005 0.88
62 Whole-body vibration training elevates creatine kinase levels in sedentary subjects. Swiss Med Wkly 2011 0.88
63 Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids. J Appl Physiol (1985) 2004 0.87
64 Relapsing acute respiratory failure induced by minocycline. Chest 2003 0.86
65 Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag 2008 0.86
66 Major impact of body position on arterial stiffness indices derived from radial applanation tonometry in pregnant and nonpregnant women. J Hypertens 2012 0.85
67 Functional late outgrowth endothelial progenitors isolated from peripheral blood of burned patients. Burns 2012 0.85
68 High-frequency oscillation for ARDS. N Engl J Med 2013 0.85
69 Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr 2012 0.85
70 Respiratory complications of gastroesophageal reflux associated with paraesophageal hiatal hernia. J Clin Gastroenterol 2003 0.84
71 Muscarinic receptor M1 and phosphodiesterase 1 are key determinants in pulmonary vascular dysfunction following perinatal hypoxia in mice. Am J Physiol Lung Cell Mol Physiol 2008 0.83
72 Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans. Shock 2011 0.82
73 The Flagellin-TLR5 Axis: Therapeutic Opportunities. Drug News Perspect 2002 0.82
74 Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock. Shock 2003 0.81
75 Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PLoS One 2013 0.81
76 [Hepatorenal syndrome in patients with liver cirrhosis]. Nephrol Ther 2005 0.80
77 Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation. Clin Sci (Lond) 2009 0.79
78 Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. J Renin Angiotensin Aldosterone Syst 2008 0.79
79 [Hypertension: early detection of target organ damage]. Rev Med Suisse 2007 0.79
80 Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes. Microcirculation 2012 0.79
81 Pharmacological Reconditioning of Marginal Donor Rat Lungs Using Inhibitors of Peroxynitrite and Poly (ADP-ribose) Polymerase During Ex Vivo Lung Perfusion. Transplantation 2016 0.78
82 Bilateral symmetry of radial pulse in high-level tennis players: implications for the validity of central aortic pulse wave analysis. J Hypertens 2009 0.78
83 Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia. Intensive Care Med 2009 0.78
84 Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth. Basic Res Cardiol 2014 0.78
85 The role of endogenous and exogenous RasGAP-derived fragment N in protecting cardiomyocytes from peroxynitrite-induced apoptosis. Free Radic Biol Med 2012 0.78
86 Profound impact of uncomplicated pregnancy on diastolic, but not systolic pulse contour of aortic pressure. J Hypertens 2006 0.77
87 Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest 2015 0.77
88 Cardiovascular dysfunction in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol 2013 0.77
89 [Pathophysiological mechanisms of organ dysfunction in sepsis]. Rev Med Suisse 2010 0.77
90 No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus. Microcirculation 2014 0.76
91 Brachial or wrist blood pressure in obese patients: which is the best? Blood Press Monit 2008 0.76
92 Open-lung biopsy for ARDS patients. Chest 2004 0.75
93 A large-bolus injection, but not a continuous infusion of sodium selenite improves outcome in peritonitis. Shock 32: 140-146, 2009. Shock 2009 0.75
94 Poly(adenosine diphosphate-ribose) polymerase: A novel actor in mesenteric complications of cardiopulmonary bypass. Crit Care Med 2004 0.75
95 [Exertional heatstroke]. Rev Med Suisse 2012 0.75
96 [From triumphant medicine to humility]. Rev Med Suisse Romande 2004 0.75
97 No implication of thromboxane prostanoid receptors in reactive hyperemia of skin and skeletal muscle in human forearm. J Cardiovasc Pharmacol 2013 0.75
98 Images in cardiovascular medicine. Rapid resolution of massive lung abscesses complicating tricuspid-valve endocarditis. Circulation 2006 0.75
99 The hemodynamics of septic shock: a historical perspective. Curr Vasc Pharmacol 2013 0.75
100 HeartMate 3 in Lowest INTERMACS Profile Cohort: The Swiss Experience. ASAIO J 2017 0.75
101 Acute liver failure complicating exertional heat stroke: possible role of hypophosphatemia. Curr Sports Med Rep 2015 0.75
102 [New therapeutic strategies in severe sepsis and septic shock]. Rev Med Suisse Romande 2004 0.75
103 Desensitization of thermal hyperemia in the skin is reproducible. Microcirculation 2012 0.75
104 [Infective endocarditis: update]. Rev Med Suisse Romande 2004 0.75
105 [Value of non-invasive ventilation in intensive care]. Rev Med Suisse Romande 2004 0.75
106 [Epidemiology, diagnosis, and treatment of pulmonary embolism]. Rev Med Suisse Romande 2004 0.75
107 Severe rhabdomyolysis following venlafaxine overdose. Ther Drug Monit 2005 0.75
108 [Heart arrest: which reality and which training for the practitioner?]. Rev Med Suisse Romande 2004 0.75
109 [Inotropic agents for treatment of acute heart failure syndromes in intensive care]. Rev Med Suisse 2009 0.75
110 [Left ventricular assist devices in cardiogenic shock and chronic refractory heart failure]. Rev Med Suisse 2012 0.75